GLP-1 RA (Ozempic, et al.) Litigation; Camp Lejeune Contaminated Water Litigation; Tylenol ASD/ADHD Litigation• Super Lawyers, New York Metro Rising Stars (2020-2024)• Best Lawyers, Ones to Watch in America – Product Liability Litigation - Plaintiffs (2021-2025); Mass Tort Litigation/Class Actions - Plaintiffs (2021-2025)

➢ Awards and Recognition• Super Lawyers, New Jersey Rising Stars (2022-2023), New York Metro Rising Stars (2020-2023)• Best Lawyers, Ones to Watch in America – Product Liability Litigation - Plaintiffs (2021-2024); Mass Tort Litigation/Class Actions - Plaintiffs (2021-2024) • The National Law Journal, Elite Trial Lawyers – Products Liability Firm of the Year (2022)• The National Trial Lawyers, Trial Team of the Year (Finalist, 2017, Konrad v. AbbVie, et al.)• The John C. Lifland American Inn of Court, Master (2023-2024); Lead Barrister (2022-2023); Barrister (2018-2022); Student (2014-2018)➢ Representative Matters• Accutane Litigation – Significant role in briefing that led NJ Supreme Court to reinstate $25 million verdict (McCarrell v. Hoffmann-La Roche, Inc., 153 A.3d 207 (N.J. 2017)) and pair of appellate decisions reversing trial court.• Testosterone Replacement Therapy MDL – Key member of successful bellwether trial teams that won plaintiff verdicts totaling ~ $300 million, leading to global settlement.• 3M Combat Arms MDL – Oversaw wave discovery; took/defended dozens of depositions; Daubert and dispositive briefing.• National Opioids Litigation – Key role managing discovery and factual investigation in MDL and other venues.• Proton Pump Inhibitor MDL – Oversaw wave discovery and bellwether trial workup.• Diesel Emissions Litigation – Significant role in class actions against several U.S. and German car companies.

Multicounty Litigation, including the following matters:- Alloderm- Gadolinium- HRT- Propecia- Risperdal/Seroquel/Zyprexa- Zometa/Aredia

Composed bench brief focusing on cross jurisdictional tolling and opt-out notice requirements under Louisiana law (Hurricane Katrina class action)

Trial and pre-trial experience, complex multi-district pharmaceutical litigation experience (allegations of off-label promotion; Neurontin MDL and denial of class certification; Lyrica litigation), commercial litigation experience (dual-track litigation in NY and TX state courts relating to funding for private equity buyout of Clear Channel), dedication to pro bono initiatives

Gained valuable experience working with Interest Rate Swaps, Swaptions, and Credit Derivatives